Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis

被引:79
作者
Fazekas, F
Strasser-Fuchs, S
Schmidt, H
Enzinger, C
Ropele, S
Lechner, A
Flooh, E
Schmidt, R
Hartung, HP
机构
[1] Karl Franzens Univ Graz, Dept Neurol, A-8036 Graz, Austria
[2] Karl Franzens Univ Graz, MRI Inst, A-8036 Graz, Austria
[3] Inst Med Biochem, A-8010 Graz, Austria
关键词
multiple sclerosis; apolipoprotein E genotype; magnetic resonance imaging;
D O I
10.1136/jnnp.69.1.25
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives-Clinical reports have speculated on a more severe course of multiple sclerosis in patients with the apolipoprotein E (apoE) epsilon 4 allele. As this could be reflected by differences in the severity of tissue damage MRI was used to obtain further support for a disease modifying effect of the apoE genotype. Methods-Brain MR scans of 83 patients (mean age 35.5 (SD 9.5 years) who participated in a cross sectional study on the distribution of genotype patterns in multiple sclerosis. The total lesion load on proton density weighted (T2-LL) and T1 weighted scans (T1-LL) obtained with conventional spin echo sequences at 1.5 T was measured. A "black hole" ratio ((T1-LL/T2-LL)x100) was also calculated. This indicates the proportion of multiple sclerosis lesions with more severe tissue damage and may reflect disease aggressiveness or quality of repair. Results-Patients with the apoE-epsilon 3/epsilon 4 genotype (n=19) showed a nonsignificantly greater T2-LL (16.0 (SD 14.0) cm(3)) than patients with the epsilon 2/epsilon 3 (n=11; 13.3 (9.5) cm(3)) or the epsilon 3/epsilon 3 genotype (n=49; 9.4 (SD 9.2) cm(3)). Both the T1-LL (2.6 (SD 3.3) v 1.6 (SD 2.4) and 1.2 (SD 3.0) cm(3); p=0.04) and the black hole ratio (14.3 SD 11.9) v 7.4 (SD 9.3) and 8.4 (SD 13.3)%; p=0.02), however, were significantly higher in epsilon 3/epsilon 4 patients. Similar differences were seen when comparing patients with at least one epsilon 4 allele with the remainder of the group. Conclusions-These data support speculations on a modulation of multiple sclerosis severity by the apoE genotype which can be attributed to more extensive tissue destruction or less efficient repair in carriers of the epsilon 4 allele.
引用
收藏
页码:25 / 28
页数:4
相关论文
共 25 条
[1]   A ROLE FOR APOLIPOPROTEIN-E, APOLIPOPROTEIN-A-I, AND LOW-DENSITY LIPOPROTEIN RECEPTORS IN CHOLESTEROL TRANSPORT DURING REGENERATION AND REMYELINATION OF THE RAT SCIATIC-NERVE [J].
BOYLES, JK ;
ZOELLNER, CD ;
ANDERSON, LJ ;
KOSIK, LM ;
PITAS, RE ;
WEISGRABER, KH ;
HUI, DY ;
MAHLEY, RW ;
GEBICKEHAERTER, PJ ;
IGNATIUS, MJ ;
SHOOTER, EM .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (03) :1015-1031
[2]   Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology [J].
Bruck, W ;
Bitsch, A ;
Kolenda, H ;
Bruck, Y ;
Stiefel, M ;
Lassmann, H .
ANNALS OF NEUROLOGY, 1997, 42 (05) :783-793
[3]   Preliminary observations on APOE ε4 allele and progression of disability in multiple sclerosis [J].
Chapman, J ;
Sylantiev, C ;
Nisipeanu, P ;
Korczyn, AD .
ARCHIVES OF NEUROLOGY, 1999, 56 (12) :1484-1487
[4]   Association of the APOE ε4 allele with disease activity in multiple sclerosis [J].
Evangelou, N ;
Jackson, M ;
Beeson, D ;
Palace, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 67 (02) :203-205
[5]   Effect of training and different measurement strategies on the reproducibility of brain MRI lesion load measurements in multiple sclerosis [J].
Filippi, M ;
Gawne-Cain, ML ;
Gasperini, C ;
vanWaesberghe, JH ;
Grimaud, J ;
Barkhof, F ;
Sormani, MP ;
Miller, DH .
NEUROLOGY, 1998, 50 (01) :238-244
[6]   Apolipoprotein E polymorphism in multiple sclerosis [J].
Gervais, A ;
Gaillard, O ;
Plassart, E ;
Reboul, J ;
Fontaine, B ;
Schuller, E .
ANNALS OF CLINICAL BIOCHEMISTRY, 1998, 35 :135-136
[7]  
HIXON JE, 1990, J LIPID RES, V31, P545
[8]  
HOGH P, 1998, EUR J NEUROL S3, V5, P121
[9]  
KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
[10]   Defining the clinical course of multiple sclerosis: Results of an international survey [J].
Lublin, FD ;
Reingold, SC .
NEUROLOGY, 1996, 46 (04) :907-911